Considering the conflicting functions of TGF-β1 in cancer development, it is not surprising that general inhibition of TGF-β1 expression may accelerate the progression of preneoplastic lesions, in which TGF-β1 still acts as a tumor suppressor. Here, TGFB1 is linked to cancer.